Center for Public Health, Medical University of Vienna, Vienna, Austria,
Center for Public Health, Medical University of Vienna, Vienna, Austria.
Eur Addict Res. 2019;25(2):80-92. doi: 10.1159/000496351. Epub 2019 Feb 18.
Attention-deficit hyperactivity disorder (ADHD) often coincides with substance abuse and delinquency. A sample of opioid-maintained inmates was assessed for symptoms of ADHD, substance abuse history, types of offense, psychiatric comorbidities, and psychopharmacological treatment using a standardized battery of instruments.
Adult inmates (n = 133, mean age 35.7 years, 21.8% female) in opioid-maintenance therapy (OMT) were administered the Adult ADHD self-report scale, Wender Utah Rating Scale, Mini International Neuropsychiatric Interview, -European Addiction Severity Index.
Fifty percent screened positive for childhood and 17% for adult ADHD, four (3.1%) received ADHD medication. Inmates with ADHD symptom status were significantly younger at first substance abuse, reported more drug overdoses, longer duration of cocaine and prescribed medication abuse and more in- and outpatient treatments (all p < 0.05). For all inmates in OMT a high rate of psychiatric comorbidities was observed (78.9%).
There is a need for assessment of ADHD and other psychiatric comorbidities in OMT prisoners. Evidence-based treatment should be routinely provided.
注意力缺陷多动障碍(ADHD)常与物质滥用和犯罪行为同时发生。采用标准化的成套工具,对一组接受阿片类药物维持治疗的囚犯进行 ADHD 症状、物质滥用史、犯罪类型、精神共病和精神药理学治疗评估。
对接受阿片类药物维持治疗(OMT)的成年囚犯(n=133,平均年龄 35.7 岁,21.8%为女性)进行成人 ADHD 自评量表、Wender Utah 评定量表、Mini 国际神经精神访谈、-欧洲成瘾严重程度指数评估。
50%的囚犯筛查出儿童时期 ADHD,17%筛查出成人 ADHD,4 人(3.1%)接受 ADHD 药物治疗。有 ADHD 症状的囚犯首次物质滥用的年龄明显更小,报告的药物过量更多,可卡因和处方药物滥用的持续时间更长,住院和门诊治疗次数更多(均 p<0.05)。所有接受 OMT 的囚犯都存在较高的精神共病率(78.9%)。
需要对 OMT 囚犯进行 ADHD 及其他精神共病评估。应常规提供基于证据的治疗。